Article

Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators

Department of Medicine, Division of Rheumatology, Stanford University, Palo Alto, California, USA.
Arthritis care & research 07/2010; 62(7):993-1001. DOI: 10.1002/acr.20150
Source: PubMed

ABSTRACT Osteoporosis and fragility fractures are associated with significant morbidity for patients with systemic lupus erythematosus (SLE). New quality indicators (QIs) for SLE advise bone mineral density testing, calcium and vitamin D use, and antiresorptive or anabolic treatment for specific subgroups of patients receiving high-dose steroids.
Subjects were participants in the University of California, San Francisco Lupus Outcomes Study, an ongoing longitudinal study of patients with physician-confirmed SLE, in 2007-2008. Patients responded to an annual telephone survey and were queried regarding demographic, clinical, and other health care-related variables. Multiple logistic regression was used to predict receipt of care per the QIs described above.
One hundred twenty-seven patients met the criteria for the formal definitions of the denominators for QI I (screening) and QI II (calcium and vitamin D); 91 met the formal criteria for QI III (treatment). The proportions of patients receiving care consistent with the QIs were 74%, 58%, and 56% for QIs I, II, and III, respectively. In a sensitivity analysis of all steroid users (n = 427 for QI I and II and n = 224 for QI III), rates were slightly lower. Predictors of receiving care varied by QI and by denominator; however, female sex, older age, white race, and longer disease duration were associated with higher-quality care.
Bone health-related care in this community-based cohort of SLE patients is suboptimal. Quality improvement efforts should address osteoporosis prevention and care among all SLE patients, especially those receiving high-dose, prolonged steroids.

0 Followers
 · 
137 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent wavelet research has primarily focused on real-valued wavelet bases. However, complex wavelet bases offer a number of potential advantageous properties. For example, it has been suggested that the complex wavelets can be used as a vestigial sideband (VSB) filter in multiuser communications C. J. Zarowski (2000). In this paper, we make an extension to the method of Davidson, Luo and Wongf (2000). We present a general method to design optimal complex-valued M-band filters and M-band wavelets. This method is more efficient and accurate than the previous linear programming problem (LPP) methods. And some examples of optimal wavelet design are provided. We also analyze the tradeoff between the peak stop band level (PSL) and stop band energy ratio (SER) of the optimal filters. Because this is important in designing waveforms with prescribed spectral characteristics.
    Communications, Computers and signal Processing, 2003. PACRIM. 2003 IEEE Pacific Rim Conference on; 09/2003
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D is an essential steroid hormone, with well established effects on mineral metabolism, skeletal health, and recently established effects on the cardiovascular and immune systems. Vitamin D deficiency is highly prevalent and evidence is mounting that it contributes to the morbidity and mortality of multiple chronic diseases, including systemic lupus erythematosus (SLE). Patients with SLE avoid the sun because of photosensitive rashes and potential for disease fare, so adequate oral supplementation is critical. This review will describe the prevalence of vitamin D deficiency in patients with SLE, identify risk factors for deficiency, describe the consequences of deficiency, and review current vitamin D recommendations for patients with rheumatic diseases.
    Bulletin of the NYU hospital for joint diseases 01/2010; 68(3):218-22.
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is an increased risk of osteoporotic fractures and osteonecrosis often at a young age among patients with certain systemic autoimmune diseases. The loss of bone mineral density and bone integrity seen with these diseases often cannot be explained by traditional risk factors alone. In this review, we focus on rheumatoid arthritis and systemic lupus erythematosus, two systemic autoimmune diseases in which skeletal manifestations have been well described. There is recent evidence that autoimmunity and its associated inflammation and vitamin D deficiency play key roles in the pathogenesis of adverse skeletal effects. Understanding these processes carries implications for the prevention and treatment of osteoporosis and osteonecrosis among patients with autoimmune diseases.
    Current opinion in endocrinology, diabetes, and obesity 10/2010; 17(6):540-5. DOI:10.1097/MED.0b013e328340533d · 3.77 Impact Factor

Preview

Download
0 Downloads
Available from